Aveanna Healthcare Holdings Net Profit Margin 2020-2023 | AVAH
Aveanna Healthcare Holdings net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Aveanna Healthcare Holdings Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $1.90B | $-0.13B | -7.07% |
| 2023-09-30 | $1.87B | $-0.35B | -18.53% |
| 2023-06-30 | $1.83B | $-0.22B | -12.01% |
| 2023-03-31 | $1.80B | $-0.72B | -39.93% |
| 2022-12-31 | $1.79B | $-0.66B | -37.08% |
| 2022-09-30 | $1.75B | $-0.55B | -31.47% |
| 2022-06-30 | $1.72B | $-0.57B | -33.33% |
| 2022-03-31 | $1.71B | $-0.10B | -5.72% |
| 2021-12-31 | $1.68B | $-0.12B | -6.97% |
| 2021-09-30 | $1.69B | $-0.00B | -0.06% |
| 2021-06-30 | $1.64B | $-0.01B | -0.61% |
| 2021-03-31 | $1.56B | $-0.09B | -5.72% |
| 2020-12-31 | $1.50B | $-0.06B | -3.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.456B | $1.895B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.956B | 10.26 |
| Quest Diagnostics (DGX) | United States | $15.068B | 15.57 |
| DaVita (DVA) | United States | $12.004B | 14.91 |
| Chemed (CHE) | United States | $8.645B | 26.80 |
| Encompass Health (EHC) | United States | $8.509B | 21.78 |
| Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
| Option Care Health (OPCH) | United States | $5.218B | 19.75 |
| RadNet (RDNT) | United States | $3.843B | 104.00 |
| Amedisys (AMED) | United States | $3.017B | 21.38 |
| LifeStance Health (LFST) | United States | $2.641B | 0.00 |
| Astrana Health (ASTH) | United States | $2.147B | 26.80 |
| Addus HomeCare (ADUS) | United States | $1.602B | 22.92 |
| U.S Physical Therapy (USPH) | United States | $1.601B | 41.49 |
| Pennant (PNTG) | United States | $0.647B | 34.24 |
| Atai Life Sciences (ATAI) | Germany | $0.355B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.021B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.012B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |